Skip to main content
Clinical Trials/NCT06535958
NCT06535958CompletedNot Applicable

Impact of Oral Hygiene Instructions in the Resolution of Peri-implant Mucositis. A Randomized Clinical Trial

Universitat Internacional de Catalunya1 site in 1 country56 target enrollmentStarted: September 16, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
56
Locations
1
Primary Endpoint
Modified bleeding index

Study Overview

Brief Summary

Peri-implant mucositis (PM) over dental implants is a highly prevalent disease characterized by inflammation of the peri-implant mucosa without loss of supporting bone around implants. If untreated, PM may progress into peri-implantitis, which may ultimately lead to implant loss. Multiple clinical studies have described a cause-effect relationship between the accumulation of biofilm and the development of PM and therefore effective oral hygiene practices and professional biofilm control are fundamental in their prevention and management. As it was stated in the latest expert consensus on the prevention and treatment of peri-implant diseases, up to date, the treatment of PM includes mechanical professional cleaning associated with oral hygiene instructions (OHI). However, the impact of OHI by itself is not known. This randomized clinical trial over 56 patients aims to identify if there is any superiority of individualized OHI and mechanical/physical instrumentation over OHI alone. The main objective is to evaluate the resolution of the disease, by means of reduction of modified bleeding index (mBI) 1 and 3 months after treatment. Secondary objectives include evaluating microbiological changes and determining if the extent of inflammation measured as the initial mBI could have any impact on PM resolution after different treatment modalities.In addition, the hypotheses formulated are as follows;

  • The proper oral hygiene measures conducted by the patient after individualized OHI will achieve resolution of PM in a clinically relevant proportion of patients.
  • The proper oral hygiene measures conducted by the patient after individualized OHI will reduce the expression of peri-implant pathogens as much as the combination of individualized OHI and professional mechanical debridement in a clinically relevant proportion of patients.
  • The proper oral hygiene measures conducted by the patient after individualized OHI will reduce mBI as much as the combination of individualized OHI and professional mechanical debridement in a clinically relevant proportion of patients.
  • The extent of inflammation measured as the mBI could be related with the degree of resolution of the disease according to the treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Presence of, at least, one titanium implant that have been more than one year in function and exhibits PM, defined as bleeding on gentle probing (0.20 N) in at least one peri-implant site.
  • •No signs of loss of supporting bone after initial bone remodelling. In cases where baseline radiograph is available, it will be used for comparison, otherwise a maximum of 2 mm of crestal bone loss will be accepted
  • •Presence of >1 mm of keratinized peri-implant mucosa.
  • •Absence of systemic diseases that could influence the outcome of the therapy (i.e. controlled diabetes, with HbA1c<7, patients will be included).
  • •Non-smoker or light smoking status in smokers (<10 cigarettes/day)

Exclusion Criteria

  • •Untreated periodontal conditions.
  • •Pregnant or lactating women.
  • •Patients who received systemic antibiotics in the last 3 months.
  • •Patients who received treatment of PM in the past 3 months.
  • •Patients receiving corticoids or medications known to have effect on gingival growth (i.e., calcium channel antagonists, immunosuppressants or antiepileptic drugs)

Arms & Interventions

Control Group (OHI+PMPR)

Experimental

Intervention: OHI (Behavioral)

Control Group (OHI+PMPR)

Experimental

Intervention: OHI+PMPR (Procedure)

Test group (OHI)

Experimental

Intervention: OHI (Behavioral)

Outcomes

Primary Outcomes

Modified bleeding index

Time Frame: At baseline, 1 and 3 months after treatment

An electronic pressure-calibrated probe is used. The index is measured tooth by tooth, and later averaged. The minimum value is 0 and the maximum value is 3, with the best value being 0 and the worst value being 3.

Secondary Outcomes

  • Full mouth probing pocket depth(At baseline, 1 and 3 months after treatment)
  • Microbiological test(At baseline, 1 and 3 months after treatment.)
  • Full mouth plaque Index(At baseline, 1 and 3 months after treatment)
  • Full mouth bleeding index(At baseline, 1 and 3 months after treatment)
  • Suppuration on probing(At baseline, 1 and 3 months after treatment)
  • Implant probing pocket depth(At baseline, 1 and 3 months after treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Beatriz de Tapia

Assistant professor, Department of Periodontology, Universitat Internacional de Catalunya (UIC)

Universitat Internacional de Catalunya

Study Sites (1)

Loading locations...

Similar Trials